BMRN
Price
$56.65
Change
+$1.38 (+2.50%)
Updated
Jun 6 closing price
Capitalization
10.6B
59 days until earnings call
IBO
Price
$0.47
Change
-$0.03 (-6.00%)
Updated
Jun 6 closing price
Capitalization
6.02M
Interact to see
Advertisement

BMRN vs IBO

Header iconBMRN vs IBO Comparison
Open Charts BMRN vs IBOBanner chart's image
BioMarin Pharmaceutical
Price$56.65
Change+$1.38 (+2.50%)
Volume$2.13M
Capitalization10.6B
Impact BioMedical
Price$0.47
Change-$0.03 (-6.00%)
Volume$248.14K
Capitalization6.02M
BMRN vs IBO Comparison Chart
Loading...
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IBO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMRN vs. IBO commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRN is a Buy and IBO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (BMRN: $58.09 vs. IBO: $0.50)
Brand notoriety: BMRN and IBO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMRN: 109% vs. IBO: 3%
Market capitalization -- BMRN: $10.6B vs. IBO: $6.02M
BMRN [@Biotechnology] is valued at $10.6B. IBO’s [@Biotechnology] market capitalization is $6.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRN’s FA Score shows that 0 FA rating(s) are green whileIBO’s FA Score has 0 green FA rating(s).

  • BMRN’s FA Score: 0 green, 5 red.
  • IBO’s FA Score: 0 green, 5 red.
According to our system of comparison, IBO is a better buy in the long-term than BMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRN’s TA Score shows that 2 TA indicator(s) are bullish while IBO’s TA Score has 3 bullish TA indicator(s).

  • BMRN’s TA Score: 2 bullish, 3 bearish.
  • IBO’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both BMRN and IBO are a bad buy in the short-term.

Price Growth

BMRN (@Biotechnology) experienced а -0.67% price change this week, while IBO (@Biotechnology) price change was -13.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

BMRN is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMRN($10.6B) has a higher market cap than IBO($6.02M). BMRN has higher P/E ratio than IBO: BMRN (20.47) vs IBO (8.10). BMRN YTD gains are higher at: -11.623 vs. IBO (-65.517). BMRN has higher annual earnings (EBITDA): 651M vs. IBO (3.14M). BMRN has more cash in the bank: 1.14B vs. IBO (2.67M). IBO has less debt than BMRN: IBO (8.01M) vs BMRN (603M). BMRN has higher revenues than IBO: BMRN (2.85B) vs IBO (0).
BMRNIBOBMRN / IBO
Capitalization10.6B6.02M176,109%
EBITDA651M3.14M20,719%
Gain YTD-11.623-65.51718%
P/E Ratio20.478.10253%
Revenue2.85B0-
Total Cash1.14B2.67M42,654%
Total Debt603M8.01M7,532%
FUNDAMENTALS RATINGS
BMRN vs IBO: Fundamental Ratings
BMRN
IBO
OUTLOOK RATING
1..100
634
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
45
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
7784
PRICE GROWTH RATING
1..100
8065
P/E GROWTH RATING
1..100
9898
SEASONALITY SCORE
1..100
9530

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IBO's Valuation (45) in the null industry is in the same range as BMRN (64) in the Biotechnology industry. This means that IBO’s stock grew similarly to BMRN’s over the last 12 months.

IBO's Profit vs Risk Rating (100) in the null industry is in the same range as BMRN (100) in the Biotechnology industry. This means that IBO’s stock grew similarly to BMRN’s over the last 12 months.

BMRN's SMR Rating (77) in the Biotechnology industry is in the same range as IBO (84) in the null industry. This means that BMRN’s stock grew similarly to IBO’s over the last 12 months.

IBO's Price Growth Rating (65) in the null industry is in the same range as BMRN (80) in the Biotechnology industry. This means that IBO’s stock grew similarly to BMRN’s over the last 12 months.

IBO's P/E Growth Rating (98) in the null industry is in the same range as BMRN (98) in the Biotechnology industry. This means that IBO’s stock grew similarly to BMRN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMRNIBO
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 11 days ago
64%
Bullish Trend 11 days ago
83%
Momentum
ODDS (%)
Bearish Trend 11 days ago
79%
Bearish Trend 11 days ago
90%
MACD
ODDS (%)
Bearish Trend 11 days ago
68%
Bullish Trend 11 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
64%
Bearish Trend 11 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
62%
Bullish Trend 11 days ago
5%
Advances
ODDS (%)
Bullish Trend 19 days ago
60%
Bullish Trend 18 days ago
82%
Declines
ODDS (%)
Bearish Trend 17 days ago
62%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 11 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 11 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IBO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

BMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with ITOS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then ITOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRN
1D Price
Change %
BMRN100%
-0.03%
ITOS - BMRN
50%
Loosely correlated
+17.94%
IBO - BMRN
46%
Loosely correlated
-6.44%
IONS - BMRN
43%
Loosely correlated
-2.67%
TECH - BMRN
40%
Loosely correlated
-1.56%
KRYS - BMRN
40%
Loosely correlated
-2.44%
More

IBO and

Correlation & Price change

A.I.dvisor indicates that over the last year, IBO has been loosely correlated with BMRN. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if IBO jumps, then BMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IBO
1D Price
Change %
IBO100%
-6.44%
BMRN - IBO
46%
Loosely correlated
-0.03%
ITOS - IBO
44%
Loosely correlated
+17.94%
NCNA - IBO
29%
Poorly correlated
-3.85%
APVO - IBO
27%
Poorly correlated
-6.50%
ADAG - IBO
25%
Poorly correlated
-2.89%
More